Skip to content

REPROBIOL

Active Private limited companyfounded 2007active for 19 yearsRue Pelé-Bois 20, 4590 OuffetKBO/BCE: BE 0886.862.189 subsidiary of #4 company by equity in Ouffet

Lifetime

19 annual accounts with figures on one time axis
peak of €604,210 in 2023
€479,821▼ 5.0%
lowest -€68,085 in 2016
€71,400▼ 25.1%
peak of €1.5m in 2024
€1.5m▼ 0.4%
€425,138▲ 31.9%
peak of 5.8 FTE in 2025
5.8 FTE▲ 3.6%
Board1 name since 2016
1 director
Owners
62%
Documentsfilings and deeds
20-06-202641 days before the deadline
2025abbreviated format
Result from €95,318 to €71,400Dividend €75,000Debts from €322,356 to €425,138Cash from €342,878 to €650,344

Key points

from the 2025 annual accounts

Equity

€1.5m ▼ 0.4%
1.52024+0.07Profit-0.08Dividend1.52025

REPROBIOL paid out €75,000 in dividends. That is 105% of the 2025 profit.

Turnover

≈ €1.7m estimated

The accounts state no turnover.

Debts

€425,138 ▲ 31.9%
Suppliers
+93,901
Other debts
+55,000
The rest
-46,119

Debts rose by €102,782 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Staff

6 employees on 31-12-2025
242021212023432024232025

In 2025, 2 employees joined and 3 left.

Liquidity

3.29 was 5.58 in 2024

Short-term debts rose from €128,870 to €270,778.

Position in the sector

€1.5m

More equity than 90% of companies in retail trade. The sector median is €314,317, over 13,318 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as REPROBIOL has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for REPROBIOL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 62%score equity €255,524 (2025) · annual accounts 2025 of
  • consolidatesannual accounts 2025
Board & ownership

Recent changes

reappointed as director 1,000,000 shares · General meeting of 21-12-2023 · Gazette deed
1 manager resigning (manager) · and act as permanent representatives · General meeting of 02-07-2021 · Gazette deed
appointed as manager General meeting of 16-06-2016 · Gazette deed
Registered office moved from Pepinster to Ouffet The registered office moved from rue du Tilleul 198, 4861 Pepinster (Soiron) to rue Pelé-Bois 20, 4590 Ouffet · Capital of €18,600, 100 shares · General meeting of 30-06-2016 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
REPROBIOL Ouffet - - 78.0% 5.8
envergure invest Tubize €2.2m 1.9% 8.8% 5.3
PHARMACIE RONLEZ Ath - - 36.0% 5.8
PHARMACIE DU ROC Tournai - - 19.2% 5.1
PHARMACIE DE RECOGNE Libramont-Chevigny - - 15.4% 5.4
OPNIPHAR Buggenhout - - 28.1% 5.5
PHARMACIE HOREMANS Charleroi €2.3m 2.3% 58.2% 4.8

These companies have the same main activity as REPROBIOL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.7m and €2.2m, founded between 2004 and 2008.

Official details

Source: KBO
Status
Active since 31-01-2007Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Joint committees
116Chemical industry
207White-collar workers in the chemical industry · annual accounts 2022
Establishment unit
2.159.957.1014590 Ouffet, registered on 01-03-2007
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

€1.9m▲ 5.3%
Employeeson 31-12-2025
6▼ 14.3%
Filing
Filed on 20-06-2026, 41 days before the end of the filing period
Financials

Insights on REPROBIOL

REPROBIOL files the abbreviated format. That format states no turnover. The gross margin rose from €161,358 in 2007 to €479,821 in 2025.

The balance sheet grew most from 2013 to 2015 through fixed assets.

holds 62% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about REPROBIOL

What is the company number of REPROBIOL?
The company number of REPROBIOL is 0886.862.189. The VAT number is the same number with BE in front: BE 0886.862.189.
Where is REPROBIOL based?
The registered office is at Rue Pelé-Bois 20, 4590 Ouffet.Company details
What does REPROBIOL do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of REPROBIOL?
REPROBIOL is a private limited company (BV).
When was REPROBIOL founded?
REPROBIOL was founded on 31-01-2007.
Is REPROBIOL still active?
Yes, REPROBIOL is an active enterprise in the KBO register.
How many employees does REPROBIOL have?
REPROBIOL had an average of 5.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does REPROBIOL fall under?
In its 2022 annual accounts, REPROBIOL states joint committees 116 (Chemical industry) and 207 (White-collar workers in the chemical industry).
What is the turnover of REPROBIOL?
The turnover in financial year 2025 is about €1.7m. This figure is estimated from the gross margin of €479,821 and 42 comparable companies (NACE 477). It probably lies between €1.3m and €2.3m.
Is REPROBIOL profitable?
In financial year 2025, REPROBIOL made a profit of €71,400.
Where can I find the annual accounts of REPROBIOL?
REPROBIOL filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of REPROBIOL due?
REPROBIOL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.